Zefylti

Zefylti (Filgrastim) is a biologic medication used to stimulate white blood cell production. It supports recovery in patients undergoing chemotherapy or stem cell transplants. This EU-manufactured injection is designed for intravenous or subcutaneous use. Always consult a healthcare provider for personalized guidance.

Zefylti (Filgrastim) is commonly used to reduce the risk of infection in patients receiving chemotherapy. It may also aid in the mobilization of stem cells for transplant procedures. This medication helps boost white blood cell counts, supporting immune function during treatment. Patients with severe chronic neutropenia may also benefit from its effects.

Zefylti works by encouraging the bone marrow to produce more white blood cells, which can help the body fight infections. Users may experience improved energy levels as their immune system recovers. Some individuals report temporary bone or muscle discomfort as the medication takes effect. These effects are typically mild and resolve over time.

Store Zefylti in a refrigerator and protect it from light until ready for use. Avoid shaking the vial or syringe vigorously, as this may affect the medication’s stability. Keep out of reach of children and pets. Dispose of used needles and vials properly to prevent accidental injury or contamination.

Zefylti may interact with other medications that affect bone marrow function, such as certain chemotherapy drugs. Combining it with lithium could enhance its effects, potentially increasing white blood cell counts further. Always inform your healthcare provider about all medications and supplements you are taking before starting Zefylti.